The global elastography imaging market size was estimated to be USD 2.13 billion in 2023 and is expected to reach at USD 4.63 billion by 2034 with a CAGR of 7.31% during the forecast period 2024-2034. A strong preference for minimally or non-invasive surgical procedures, surge in number of ongoing studies to evaluate potential applications of elastography, increase in the prevalence of chronic liver and breast cancer, growing demand for sophisticated diagnostic techniques, and rise in the launch of advanced elastography imaging devices are some of the key factors boosting the market growth.
Rise in the launch of advanced elastography imaging devices is predicted to boost the market growth during the forecast period. The elastography technique is gaining growing favor and approval from both patients and doctors, mainly due to its non-invasive nature and accurate evaluation of mechanical properties in tissues. State-of-the-art elastography systems not only provide in-depth quantitative analysis but also deliver qualitative diagnostic capabilities. For instance, in March 2022, Fujifilm Healthcare Europe has unveiled the latest Arietta ultrasound series, featuring Arietta 850 DeepInsight and Arietta 650 DeepInsight. These systems facilitate comprehensive diagnostics for hepatic diseases like hepatitis, hepatic fibrosis, and hepatic cirrhosis, utilizing Real-time Tissue Elastography (RTE) and Shear Wave Measurement (SWM). These techniques provide color-coded and quantified assessments of tissue stiffness.
By modality, ultrasound was the highest revenue-grossing segment in the global elastography imaging market in 2023 owing to the advantages of affordability, quick turnaround time, & widespread accessibility, growing introduction of advanced ultrasound systems, and the gradual replacement of traditional ultrasound devices used for organ assessment and biopsy procedures by ultrasound elastography. For instance, in September 2022, Boston Imaging, the digital radiography and ultrasound division of Samsung, has unveiled an innovative ultrasound system, V7. Designed for diverse clinical applications, this system integrates S-Shearwave Imaging capabilities, providing a quantitative and non-invasive assessment of tissue stiffness in clinical environments. Additionally, MRI is predicted to grow at the fastest CAGR during the forecast period as it is preferred diagnostic method for liver diseases due to its accurate results and the non-invasive nature of the procedure. The precise outcomes of MRI make it an effective tool for diagnosing advanced liver fibrosis, helping assess the severity of liver disease and determining the suitable treatment course.
By application, general imaging was the highest revenue-grossing segment in the global elastography imaging market in 2023 owing to its extensive application in diverse medical fields, increasing use in diagnostic procedures such as liver disease diagnosis, cancer detection, & musculoskeletal assessments, and the introduction of new systems are on the rise. For instance, in June 2023, Nikon Instruments Inc. is pleased to present the "ECLIPSE Ui," a comprehensive microscope-based viewing system designed for both in-person clinical observation and remote pathological assessment, with details about its development and launch. Additionally, obstetrics/gynecology is predicted to grow at the fastest CAGR during the forecast period owing to the rising need for precise and non-invasive diagnostic tools in breast health assessment. Elastography imaging serves as a valuable complement to conventional breast imaging techniques, offering insights into tissue stiffness that assist in the early detection and characterization of breast lesions.
By end-user, hospital was the highest revenue-grossing segment in the global elastography imaging market in 2023 owing to the number of surgeries utilizing ultrasound and MRI-based elastography is on the rise, increasing prevalence of cancer cases, and growing adoption of innovative technologies in these healthcare facilities. Additionally, imaging centers is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption of non-invasive surgical & diagnostic procedures by professionals, increasing trend of automation among surgeons & other specialists, and surge in the introduction of advanced devices in these settings. For instance, in November 2023, ZEISS has introduced new products, ZEISS Lattice SIM 3 and ZEISS Lattice SIM 5, incorporating structured illumination to overcome the inherent resolution limitations of light microscopy.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing need for early disease diagnosis, quick integration of elastography imaging into clinical procedures, advantageous reimbursement environment, expanding significance of using these systems among end users, and increase in the introduction of new systems. For instance, in November 2022, PENTAX Medical has introduced its latest Performance Endoscopic Ultrasound (EUS) system in Canada, comprising the advanced ARIETTA 65 PX ultrasound scanner and the top-tier J10 Series Ultrasound Gastroscopes. The J10 Series Ultrasound Gastroscope, combined with the ARIETTA 65 PX, provides superior image quality, real-time tissue elastography, and improved access for therapeutic procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increased need for sophisticated diagnostic tools, an increase in research and development activities, an aging population, better healthcare facilities, public awareness of the therapeutic potential of ultrasound technology, and an increase in the introduction of new devices. For instance, in May 2022, Mindray introduced Resona I9 Advanced Technologies, featuring HiFR Sound Touch Elastography. This innovation enables smoother transitions and quicker refresh rates, ensuring more consistent acquisition and assessment in real-time 2D shear wave imaging.
Rise in the launch of advanced elastography imaging devices is predicted to boost the market growth during the forecast period. The elastography technique is gaining growing favor and approval from both patients and doctors, mainly due to its non-invasive nature and accurate evaluation of mechanical properties in tissues. State-of-the-art elastography systems not only provide in-depth quantitative analysis but also deliver qualitative diagnostic capabilities. For instance, in March 2022, Fujifilm Healthcare Europe has unveiled the latest Arietta ultrasound series, featuring Arietta 850 DeepInsight and Arietta 650 DeepInsight. These systems facilitate comprehensive diagnostics for hepatic diseases like hepatitis, hepatic fibrosis, and hepatic cirrhosis, utilizing Real-time Tissue Elastography (RTE) and Shear Wave Measurement (SWM). These techniques provide color-coded and quantified assessments of tissue stiffness.
By modality, ultrasound was the highest revenue-grossing segment in the global elastography imaging market in 2023 owing to the advantages of affordability, quick turnaround time, & widespread accessibility, growing introduction of advanced ultrasound systems, and the gradual replacement of traditional ultrasound devices used for organ assessment and biopsy procedures by ultrasound elastography. For instance, in September 2022, Boston Imaging, the digital radiography and ultrasound division of Samsung, has unveiled an innovative ultrasound system, V7. Designed for diverse clinical applications, this system integrates S-Shearwave Imaging capabilities, providing a quantitative and non-invasive assessment of tissue stiffness in clinical environments. Additionally, MRI is predicted to grow at the fastest CAGR during the forecast period as it is preferred diagnostic method for liver diseases due to its accurate results and the non-invasive nature of the procedure. The precise outcomes of MRI make it an effective tool for diagnosing advanced liver fibrosis, helping assess the severity of liver disease and determining the suitable treatment course.
By application, general imaging was the highest revenue-grossing segment in the global elastography imaging market in 2023 owing to its extensive application in diverse medical fields, increasing use in diagnostic procedures such as liver disease diagnosis, cancer detection, & musculoskeletal assessments, and the introduction of new systems are on the rise. For instance, in June 2023, Nikon Instruments Inc. is pleased to present the "ECLIPSE Ui," a comprehensive microscope-based viewing system designed for both in-person clinical observation and remote pathological assessment, with details about its development and launch. Additionally, obstetrics/gynecology is predicted to grow at the fastest CAGR during the forecast period owing to the rising need for precise and non-invasive diagnostic tools in breast health assessment. Elastography imaging serves as a valuable complement to conventional breast imaging techniques, offering insights into tissue stiffness that assist in the early detection and characterization of breast lesions.
By end-user, hospital was the highest revenue-grossing segment in the global elastography imaging market in 2023 owing to the number of surgeries utilizing ultrasound and MRI-based elastography is on the rise, increasing prevalence of cancer cases, and growing adoption of innovative technologies in these healthcare facilities. Additionally, imaging centers is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption of non-invasive surgical & diagnostic procedures by professionals, increasing trend of automation among surgeons & other specialists, and surge in the introduction of advanced devices in these settings. For instance, in November 2023, ZEISS has introduced new products, ZEISS Lattice SIM 3 and ZEISS Lattice SIM 5, incorporating structured illumination to overcome the inherent resolution limitations of light microscopy.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing need for early disease diagnosis, quick integration of elastography imaging into clinical procedures, advantageous reimbursement environment, expanding significance of using these systems among end users, and increase in the introduction of new systems. For instance, in November 2022, PENTAX Medical has introduced its latest Performance Endoscopic Ultrasound (EUS) system in Canada, comprising the advanced ARIETTA 65 PX ultrasound scanner and the top-tier J10 Series Ultrasound Gastroscopes. The J10 Series Ultrasound Gastroscope, combined with the ARIETTA 65 PX, provides superior image quality, real-time tissue elastography, and improved access for therapeutic procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increased need for sophisticated diagnostic tools, an increase in research and development activities, an aging population, better healthcare facilities, public awareness of the therapeutic potential of ultrasound technology, and an increase in the introduction of new devices. For instance, in May 2022, Mindray introduced Resona I9 Advanced Technologies, featuring HiFR Sound Touch Elastography. This innovation enables smoother transitions and quicker refresh rates, ensuring more consistent acquisition and assessment in real-time 2D shear wave imaging.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
Study Coverage
- Market Forecast by Type, Material, Product, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Elastography Imaging Market Report 2023 - 2034
Elastography Imaging Market Analysis & Forecast by Modality 2023 - 2034 (Revenue USD Bn)
- Magnetic Resonance
- Ultrasound
Elastography Imaging Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Orthopedic and Musculoskeletal
- Cardiology
- Obstetrics/Gynecology
- Vascular
- Radiology
- Urology
- General Imaging
- Others
Elastography Imaging Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Imaging Centers
- Ambulatory Surgery Centers
- Others
Elastography Imaging Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Elastography Imaging Market: Modality Estimates & Trend Analysis
8. Elastography Imaging Market: Application Estimates & Trend Analysis
9. Elastography Imaging Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Elastography Imaging Market
12. Europe Elastography Imaging Market
13. Asia Pacific Elastography Imaging Market
14. Latin America Elastography Imaging Market
15. MEA Elastography Imaging Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Mindray Bio-Medical Electronics Co. Ltd.
- Samsung Medison Co. Ltd.
- Canon Medical Systems Corporation
- FUJIFILM Corporation
- GE Healthcare
- Esaote SpA
- Toshiba America Medical Systems Inc.
- Siemens
- Hitachi Ltd
- Koninklijke Philips N.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 2.13 Billion |
| Forecasted Market Value ( USD | $ 4.63 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
